EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
Frequently asked questions
What sector does Yulong Eco-Materials Ltd (YECO) operate in?
Yulong Eco-Materials Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Yulong Eco-Materials Ltd (YECO) current stock price?
As of the latest data, Yulong Eco-Materials Ltd stock price is $0.00, with a previous close of $0.00.
What is Yulong Eco-Materials Ltd (YECO) current market capitalization?
Yulong Eco-Materials Ltd market cap is approximately 1.02 thousand.
What is Yulong Eco-Materials Ltd (YECO) Earnings Per Share (EPS)?
The trailing EPS is $0.15.
What is Yulong Eco-Materials Ltd (YECO) Price-to-Earnings (P/E) ratio?
Yulong Eco-Materials Ltd current P/E ratio is 0.
Does Yulong Eco-Materials Ltd (YECO) pay dividends?
No. Yulong Eco-Materials Ltd does not pay a dividend.
What is Yulong Eco-Materials Ltd (YECO) beta (volatility) score?
Yulong Eco-Materials Ltd has a beta of 0.531, indicating lower volatility than the overall market.